C25 Categoría · se requiere mayor especificidad Malignant neoplasm of pancreas
ICD-10-CM C25 identifies “Malignant neoplasm of pancreas” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Capítulo 2: Neoplasms
Instrucciones del código
Use additional code2
- code to identify:
- alcohol abuse and dependence (F10.-)
Code also1
if applicable exocrine pancreatic insufficiency (K86.81)
Instrucciones de niveles superiores
Capítulos 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C15-C26 · Malignant neoplasms of digestive organs (C15-C26)
Excludes 11
Kaposi's sarcoma of gastrointestinal sites (C46.4)
Excludes 21
gastrointestinal stromal tumors (C49.A-)
Códigos más específicos
C25.0Malignant neoplasm of head of pancreasCódigo facturable y específicoC25.1Malignant neoplasm of body of pancreasCódigo facturable y específicoC25.2Malignant neoplasm of tail of pancreasCódigo facturable y específicoC25.3Malignant neoplasm of pancreatic ductCódigo facturable y específicoC25.4Malignant neoplasm of endocrine pancreasCódigo facturable y específicoC25.7Malignant neoplasm of other parts of pancreasCódigo facturable y específicoC25.8Malignant neoplasm of overlapping sites of pancreasCódigo facturable y específicoC25.9Malignant neoplasm of pancreas, unspecifiedCódigo facturable y específicoReferencias del índice oficial
Referencias desde otros códigos (1)
Inclusion terms · Conditions classifiable to C25
Historial
Historial del código
Último cambio registrado · FY2022
ModificadoSin cambios
FY2022
Vigente desde
- Cambios en instrucciones
Malignant neoplasm of pancreas
Categoría — seleccione un código más específico
CDC/NCHS · FY2022Todas las ediciones (19)
| Todas las ediciones | Vigente desde | Historial del código |
|---|---|---|
| FY2016 | 2015-10-01 | Primera aparición |
| FY2017 | 2016-10-01 | Cambios en instrucciones · Cambios en instrucciones heredadas |
| FY2018 | 2017-10-01 | Sin cambios tabulares |
| FY2019 | 2018-10-01 | Sin cambios tabulares |
| FY2020 | 2019-10-01 | Sin cambios tabulares |
| FY2020 · April | 2020-04-01 | Sin cambios tabulares |
| FY2021 | 2020-10-01 | Sin cambios tabulares |
| FY2021 · 01-01 | 2021-01-01 | Sin cambios tabulares |
| FY2022 | 2021-10-01 | Cambios en instrucciones |
| FY2022 · 04-01 | 2022-04-01 | Sin cambios tabulares |
| FY2023 | 2022-10-01 | Sin cambios tabulares |
| FY2023 · 04-01 | 2023-04-01 | Sin cambios tabulares |
| FY2024 | 2023-10-01 | Sin cambios tabulares |
| FY2024 · 04-01 | 2024-04-01 | Sin cambios tabulares |
| FY2025 | 2024-10-01 | Sin cambios tabulares |
| FY2025 · 04-01 | 2025-04-01 | Sin cambios tabulares |
| FY2026 | 2025-10-01 | Sin cambios tabulares |
| FY2026 · April | 2026-04-01 | Sin cambios tabulares |
| FY2027 | 2026-10-01 | Sin cambios tabulares |
Explora los códigos más específicos de esta categoría. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.